scholarly article | Q13442814 |
P50 | author | Shing Chuan Hooi | Q59704544 |
P2093 | author name string | Jian-Jun Liu | |
Baohua Huang | |||
P2860 | cites work | Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells | Q28200965 |
Therapy of active Crohn disease with Boswellia serrata extract H 15 | Q28201999 | ||
Highlight on the studies of anticancer drugs derived from plants in China | Q28251270 | ||
Lost in transcription: p21 repression, mechanisms, and consequences | Q28251319 | ||
Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study | Q28288426 | ||
Effects of Boswellia serrata in mouse models of chemically induced colitis | Q28292798 | ||
Effects of Boswellia serrata gum resin in patients with ulcerative colitis | Q28304612 | ||
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age | Q29618409 | ||
Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis | Q29999322 | ||
To cycle or not to cycle: a critical decision in cancer. | Q33957955 | ||
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. | Q34164259 | ||
Retinoblastoma protein partners | Q34305195 | ||
Cyclin E2, the cycle continues | Q34537668 | ||
Regulation of the eukaryotic cell cycle | Q35573603 | ||
Role of cell-cycle regulators in lung cancer | Q36167892 | ||
Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. | Q40400655 | ||
Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. | Q40485500 | ||
Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs | Q40598325 | ||
Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China | Q40625771 | ||
Boswellic acids inhibit glioma growth: a new treatment option? | Q40757397 | ||
Cdk inhibitors in development and cancer | Q41099892 | ||
Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity | Q43201405 | ||
Effects of gum resin of Boswellia serrata in patients with chronic colitis | Q43697674 | ||
Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway | Q44143115 | ||
Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. | Q44382218 | ||
Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors | Q47587322 | ||
Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture | Q47997449 | ||
Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. | Q48887158 | ||
Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. | Q50766137 | ||
Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice | Q70140866 | ||
Correlation of cell cycle analysis with Duke's staging in colon cancer patients | Q71164505 | ||
Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid | Q73584153 | ||
Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I | Q77905183 | ||
Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines | Q77952429 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colon cancer | Q18555025 |
P304 | page(s) | 1099-1107 | |
P577 | publication date | 2006-06-19 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells | |
P478 | volume | 148 |
Q43058463 | 3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity |
Q55517828 | 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. |
Q34130202 | A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells |
Q92825988 | An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases |
Q56378864 | Anti-Inflammatory Activity of Extracts: An Study on Porcine Aortic Endothelial Cells |
Q38935503 | Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats |
Q34101905 | Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells |
Q51118615 | Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumorigenesis. |
Q36435782 | Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family |
Q36000279 | Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells. |
Q39768734 | Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells |
Q37448772 | Boswellic acids: a group of medicinally important compounds. |
Q47198641 | Characterization of New Bioactive Enzyme Inhibitors from Endophytic Bacillus amyloliquefaciens RWL-1. |
Q34511512 | Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model |
Q57922384 | Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases |
Q35206870 | Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach |
Q36237525 | Nutraceuticals as potential therapeutic agents for colon cancer: a review |
Q44193644 | Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. |
Q36956879 | Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature |
Q24631327 | Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals |
Q48553803 | Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer |
Q34069637 | Retracted: Boswellic Acid Suppresses Growth and Metastasis of Human Pancreatic Tumors in an Orthotopic Nude Mouse Model through Modulation of Multiple Targets |
Q35155622 | Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer |
Q38959022 | Therapeutic potential of boswellic acids: a patent review (1990-2015). |
Q47434347 | Transcriptomic Profiling of MDA-MB-231 Cells Exposed to Boswellia Serrata and 3-O-Acetyl-B-Boswellic Acid; ER/UPR Mediated Programmed Cell Death |
Search more.